William Blair & Company’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-19,516
Closed -$570K 1425
2017
Q3
$570K Sell
19,516
-1,122
-5% -$33.1K ﹤0.01% 896
2017
Q2
$664K Buy
20,638
+97
+0.5% +$3.18K 0.01% 880
2017
Q1
$711K Buy
20,541
+342
+2% +$12.2K 0.01% 795
2016
Q4
$713K Sell
20,199
-373
-2% -$12.6K 0.01% 729
2016
Q3
$714K Buy
20,572
+757
+4% +$26.5K 0.01% 728
2016
Q2
$741K Buy
19,815
+779
+4% +$29.3K 0.01% 702
2016
Q1
$769K Sell
19,036
-121
-0.6% -$4.51K 0.01% 686
2015
Q4
$689K Sell
19,157
-35
-0.2% -$1.27K 0.01% 725
2015
Q3
$613K Sell
19,192
-4,799
-20% -$163K 0.01% 907
2015
Q2
$815K Buy
23,991
+221
+0.9% +$7.45K ﹤0.01% 1629
2015
Q1
$804K Sell
23,770
-1,808
-7% -$63K ﹤0.01% 1602
2014
Q4
$898K Sell
25,578
-9,175
-26% -$309K ﹤0.01% 1529
2014
Q3
$1.14M Sell
34,753
-2,515
-7% -$85.6K ﹤0.01% 1422
2014
Q2
$1.27M Buy
37,268
+649
+2% +$22.2K ﹤0.01% 1377
2014
Q1
$1.28M Buy
36,619
+169
+0.5% +$5.96K ﹤0.01% 1338
2013
Q4
$1.33M Buy
36,450
+596
+2% +$21.9K ﹤0.01% 1303
2013
Q3
$1.24M Sell
35,854
-132
-0.4% -$4.62K ﹤0.01% 1275
2013
Q2
$1.22M Buy
+35,986
New +$1.19M ﹤0.01% 1209

Other funds holding ACH

William Blair & Company's ACH Position: Q4 2017 in Review

William Blair & Company sold out of Accendra Health (ACH) in Q4 2017, closing a stake of 19,516 shares — an estimated $570K sold.

William Blair & Company first reported a position in ACH in Q2 2013 and held it in 18 quarters. The position peaked at $1.33M in Q4 2013. 230 funds tracked by Wall St. Rank hold ACH as of Q4 2017.

  • William Blair & Company reported no remaining Accendra Health position as of Q4 2017 after selling out during the quarter.
  • William Blair & Company sold 19,516 Accendra Health shares in Q4 2017, an estimated $570K.
  • William Blair & Company first reported a position in Accendra Health in Q2 2013 and held it in 18 quarters.
  • William Blair & Company's Accendra Health position peaked at $1.33M in Q4 2013.
  • 230 funds tracked by Wall St. Rank held Accendra Health as of Q4 2017.

Based on William Blair & Company's 13F filing for Q4 2017, filed 14 Feb 2018.